Production (Stage)
InterCure Ltd.
INCR
$1.52
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -16.11% | 17.86% | 38.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -16.11% | 17.86% | 38.55% |
| Cost of Revenue | -- | -- | 4.39% | 35.76% | 50.29% |
| Gross Profit | -- | -- | -41.89% | -2.71% | 25.00% |
| SG&A Expenses | -- | -- | -11.12% | 26.25% | 51.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -67.68% | 101.63% | 121.34% |
| Total Operating Expenses | -- | -- | -6.05% | 36.45% | 54.53% |
| Operating Income | -- | -- | -98.49% | -74.81% | -42.94% |
| Income Before Tax | -- | -- | -220.53% | -88.25% | -22.30% |
| Income Tax Expenses | -- | -- | 137.55% | -162.03% | -116.59% |
| Earnings from Continuing Operations | -- | -- | -227.34% | -40.67% | 53.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 61.76% | 193.57% | 169.94% |
| Net Income | -- | -- | -221.63% | -18.90% | 102.74% |
| EBIT | -- | -- | -98.49% | -74.81% | -42.94% |
| EBITDA | -- | -- | -77.91% | -64.02% | -34.70% |
| EPS Basic | -- | -- | -213.40% | -24.69% | 88.54% |
| Normalized Basic EPS | -- | -- | -140.28% | -101.36% | -48.16% |
| EPS Diluted | -- | -- | -216.74% | -19.14% | 114.95% |
| Normalized Diluted EPS | -- | -- | -142.06% | -101.27% | -46.16% |
| Average Basic Shares Outstanding | -- | -- | 6.83% | 25.99% | 22.80% |
| Average Diluted Shares Outstanding | -- | -- | 4.69% | 23.36% | 16.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |